A phase 2 of Cantrixil in ovarian cancer
Latest Information Update: 08 Mar 2021
At a glance
- Drugs TRXE 002 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 08 Mar 2021 New trial record
- 01 Mar 2021 According to a Kazia Therapeutics media release, the company expects to initiate this study in 2022.